Gene · 155
Papers3,802
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,802
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Conservative Bladder Management and Medical Treatment in Chronic Spinal Cord Injury Patients. | J Clin Med | 2023 | 36902808 | PubTator, text mining | PubMed |
| Clinical Significance and Tumor Microenvironment Characterization of a Novel Immune-Related Gene Signature in Bladder Cancer. | J Clin Med | 2023 | 36902678 | PubTator, text mining | PubMed |
| Characteristics and Prognosis of 8p11.23-Amplified Squamous Lung Carcinomas. | J Clin Med | 2023 | 36902501 | PubTator, text mining | PubMed |
| Epigenetic Signatures in Arterial Hypertension: Focus on the Microvasculature. | Int J Mol Sci | 2023 | 36902291 | PubTator, text mining | PubMed |
| β-Adrenoreceptors as Therapeutic Targets for Ocular Tumors and Other Eye Diseases-Historical Aspects and Nowadays Understanding. | Int J Mol Sci | 2023 | 36902129 | PubTator, text mining | PubMed |
| Electrical Remodeling in Right Ventricular Failure Due to Pulmonary Hypertension: Unraveling Novel Therapeutic Targets. | Int J Mol Sci | 2023 | 36902065 | PubTator, text mining | PubMed |
| Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure. | Int J Mol Sci | 2023 | 36901752 | PubTator, text mining | PubMed |
| Recent insights into the molecular mechanisms of simultaneous fatty acid oxidation and synthesis in brown adipocytes. | Front Endocrinol (Lausanne) | 2023 | 36896177 | PubTator, text mining | PubMed |
| Insights into β3-adrenoceptor agonism through comprehensive in silico investigation. | Comput Biol Chem | 2023 | 36889141 | PubTator, text mining | PubMed |
| β3AR-Dependent Brain-Derived Neurotrophic Factor (BDNF) Generation Limits Chronic Postischemic Heart Failure. | Circ Res | 2023 | 36884028 | PubTator, text mining | PubMed |
| Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure. | Cardiovasc Res | 2023 | 36883593 | PubTator, text mining | PubMed |
| An insight into brown/beige adipose tissue whitening, a metabolic complication of obesity with the multifactorial origin. | Front Endocrinol (Lausanne) | 2023 | 36875450 | PubTator, text mining | PubMed |
| The pharmacogenetics of the new-generation antipsychotics - A scoping review focused on patients with severe psychiatric disorders. | Front Psychiatry | 2023 | 36873203 | PubTator, text mining | PubMed |
| On the cutting edge: perspectives in bioenergetics. | Nat Rev Endocrinol | 2023 | 36869239 | PubTator, text mining | PubMed |
| Comparative study of different combinations of mirabegron and antimuscarinics in treatment for overactive bladder syndrome in elderly patients. | Tzu Chi Med J | 2023 | 36866344 | PubTator, text mining | PubMed |
| Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. | Signal Transduct Target Ther | 2023 | 36864020 | PubTator, text mining | PubMed |
| Identification of GNG7 as a novel biomarker and potential therapeutic target for gastric cancer via bioinformatic analysis and in vitro experiments. | Aging (Albany NY) | 2023 | 36863706 | PubTator, text mining | PubMed |
| The β3 adrenoceptor in proliferative retinopathies: "Cinderella" steps out of its family shadow. | Pharmacol Res | 2023 | 36863427 | PubTator, text mining | PubMed |
| β3-adrenergic receptor on tumor-infiltrating lymphocytes sustains IFN-γ-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma. | Cancer Gene Ther | 2023 | 36854895 | PubTator, text mining | PubMed |
| Age-related methylation changes in the human sperm epigenome. | Aging (Albany NY) | 2023 | 36849136 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/155/papers?page=20